Project Grant R21AG103608
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $474K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The National Institute on Aging awarded Massachusetts General Hospital (doing business as The General Hospital Corporation) $679,058 under the Aging Research program (CFDA 93.866) on July 1, 2026, to investigate whether participation in the Geriatric Emergency Department Accreditation (GEDA) program improves emergency care processes and clinical outcomes for older adults with dementia. The study combines three population-based datasets from 2022–2024 (NEDI-USA for emergency department...
- The National Institute on Aging awarded $191,193 to Beth Israel Deaconess Medical Center on September 9, 2025, under the Aging Research program (CFDA 93.866) to develop and pilot test an electronic health record-based serious illness communication intervention for older adults in emergency departments. The award supports development of SIC-ED (Serious Illness Communication-Emergency Department), an EHR-embedded intervention designed to help emergency clinicians solicit goals, values, and...
- The National Institute on Aging awarded The General Hospital Corporation (doing business as Massachusetts General Hospital) $453,750 in Project Grant funding on February 15, 2026, under the Aging Research program (CFDA 93.866). The award funds a study establishing a cohort of 100 older Chinese immigrants aged 65 and above to examine cognitive outcomes, sleep quality, and circadian function in the "zeroth generation" immigrant population—aging parents of first-generation immigrant...
- The National Institute on Aging, part of the Department of Health and Human Services, awarded $674,088 to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate how environmental and psychosocial exposures shape Alzheimer's disease and related dementias outcomes. The project introduces a novel exposome-health outcomes framework tailored to real-world data, particularly Medicare...
- The National Institute on Aging awarded Education Development Center, Inc. $320,150 under the Aging Research program (CFDA 93.866) on September 1, 2026. The research project examines elder mistreatment and self-neglect among older adults with Alzheimer's disease and related dementias, leveraging the UCLA Alzheimer's and Dementia Care (ADC) Program's longitudinal dataset of structured data and clinical notes from dementia care specialists. The study expands the existing dataset to include three...
- The National Institute on Aging awarded Brigham & Women's Hospital Inc. $943,368 on September 1, 2026, under the Aging Research program (CFDA 93.866) to investigate health care contact days—days older adults spend obtaining health care outside the home—and their impact on patient outcomes. The research addresses three primary aims. Aim 1 employs semi-structured interviews and focus groups across two large health systems serving multiple populations in five states to elicit perspectives...
- The National Institute on Aging awarded The General Hospital Corporation (Massachusetts General Hospital) $660,000 on March 15, 2026, under the Aging Research program (CFDA 93.866) to develop deep learning–based image registration and morphometric analysis tools for structural MRI-derived biomarkers in Alzheimer's disease diagnosis. The project aims to improve the sensitivity and accessibility of longitudinal morphometric metrics derived from T1-weighted structural brain MRI scans—a non-invasive...
- The National Institute on Aging awarded The General Hospital Corporation (Massachusetts General Hospital) $269,452 under the Aging Research program (CFDA 93.866) on February 18, 2026, to conduct research on proteomic aging and frailty prediction. The project integrates large-scale genetic, multi-omic, and clinical data from the UK Biobank, Multi-Ethnic Study of Atherosclerosis (MESA), FinnGen, and All of Us (combined N=70,225) to investigate the biological underpinnings of proteomic aging and...
- The National Institute on Aging awarded the University of Washington $777,500 on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct quantitative and qualitative research on interfacility transfers of older adults from emergency departments to other hospitals. The project will characterize outcomes and adverse events among transferred older adults using statewide administrative claims data, explore the experiences of older adults and care partners during transfer, and...
- The National Institute on Aging awarded The General Hospital Corporation (doing business as Massachusetts General Hospital) $463,000 under the Aging Research program (CFDA 93.866) on May 1, 2026, to support research investigating chromatin mechanisms of cytoplasmic chromatin fragments during senescence and aging. The research examines how chromatin fragments transit from the nucleus to the cytoplasm in senescent and aged cells, activating the cGAS-STING immune pathway and driving chronic...